fluconazole has been researched along with HPV Infection in 1 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
| Excerpt | Relevance | Reference |
|---|
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Palma, E | 1 |
| Recine, N | 1 |
| Domenici, L | 1 |
| Giorgini, M | 1 |
| Pierangeli, A | 1 |
| Panici, PB | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Lactobacilli Implementation to Restore a Balanced Vaginal Ecosystem: a Promising Solution Against Vaginosis, Vaginitis and HPV Infection[NCT03372395] | Phase 2 | 117 participants (Actual) | Interventional | 2015-02-28 | Completed | ||
| Probiotics Role in HPV Clearance When Coexisting Vaginal Infections[NCT05109533] | 483 participants (Actual) | Interventional | 2018-01-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for fluconazole and HPV Infection
| Article | Year |
|---|---|
Long-term Lactobacillus rhamnosus BMX 54 application to restore a balanced vaginal ecosystem: a promising solution against HPV-infection.
Topics: Administration, Intravaginal; Adult; Female; Fluconazole; Humans; Lacticaseibacillus rhamnosus; Metr | 2018 |
Long-term Lactobacillus rhamnosus BMX 54 application to restore a balanced vaginal ecosystem: a promising solution against HPV-infection.
Topics: Administration, Intravaginal; Adult; Female; Fluconazole; Humans; Lacticaseibacillus rhamnosus; Metr | 2018 |
Long-term Lactobacillus rhamnosus BMX 54 application to restore a balanced vaginal ecosystem: a promising solution against HPV-infection.
Topics: Administration, Intravaginal; Adult; Female; Fluconazole; Humans; Lacticaseibacillus rhamnosus; Metr | 2018 |
Long-term Lactobacillus rhamnosus BMX 54 application to restore a balanced vaginal ecosystem: a promising solution against HPV-infection.
Topics: Administration, Intravaginal; Adult; Female; Fluconazole; Humans; Lacticaseibacillus rhamnosus; Metr | 2018 |